Chronic Fatigue Limits Quality of Life in Imatinib-Treated CML Patients

A study of patients with chronic myeloid leukemia treated with imatinib found that chronic fatigue is the major factor that limits health-related quality of life.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news